March 31st 2025
A new study from Intermountain Health reveals that while disparities in heart disease outcomes between men and women are shrinking, women still face unique risks and challenges in diagnosis and treatment.
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
Satellite Symposia at the 2025 Oncology Nursing Society Congress
April 11-12, 2025
Register Now!
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Early HPV vaccination in children
July 13th 2023Jonathan Miller, MD, pediatrician and chief of primary care, pediatrics at Nemours Children’s Health in the Delaware Valley, spoke about the latest data regarding early human papillomavirus (HPV) vaccination in children as young as 9 years old at the 2023 Pediatric Academic Societies meeting. He also provided some clinical pearls for opening the conversation with patients’ caretakers regarding earlier HPV vaccination.
Read More
Jonathan Miller, MD, discusses early HPV vaccination in children at PAS 2023
April 29th 2023Jonathan Miller, MD, pediatrician and chief of primary care, pediatrics, at Nemours Children's Health in the Delaware Valley, spoke about the latest data regarding early HPV vaccination in children as young as 9 at the 2023 Pediatric Academic Societies meeting.
Watch
Best practices for well woman visits for the adolescent patient
March 28th 2023Millicent McCarren, MD, of Allegheny Health Network, sits down with Contemporary OB/GYN® to discuss tips, tricks, and clinical pearls for making sure your adolescent patients are coming in for their routine well woman visits.
Watch
Michael Krychman, MD, digital editor for Contemporary OB/GYN® recently attended the International Society for the Study of Women’s Sexual Health (ISSWSH), held March 2 through March 5 in St. Louis, Missouri. There he spoke to Andrew Goldstein, MD, a board-certified ob gyn who practices in Annapolis, Maryland and is the past president of ISSWSH.
Read More
Cleveland Clinic reexamines syphilis testing strategies after rise in cases
February 6th 2023After observing an increase in the rate of syphilis cases, the Cleveland Clinic Ob/Gyn & Women’s Health Institute has partnered with the Center for Pediatric Infectious Diseases to evaluate the effectiveness of current testing strategies.
Read More
How much do women really know about pelvic floor physical therapy?
June 15th 2022During a poster session of the 2022 American Urogynecologic Society and International Urogynecological Association’s 47th Annual Meeting, researchers shared a study that investigated baseline knowledge of patients with pelvic floor therapy.
Read More
Calcium supplementation could increase risk of death in older adults with cardiovascular disease
May 9th 2022An analysis of data from a Cleveland Clinic database indicates calcium supplementation in older adults with aortic stenosis was linked to an increased risk of mortality and worsening aortic stenosis.
Read More
How climate change is making your patients sick, and what you can do about it
May 7th 2022At the 2022 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting, 4 health care professionals spoke of disease states caused by climate change, and what HCPs can do to mitigate this crisis.
Read More
Using technology tools for optimal perinatal outcomes
May 6th 2022At the 2022 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting, 3 physicians talked about how apps, AI and remote blood pressure monitoring could improve perinatal outcomes and move the diversity, inclusion, and equity needle for women forward.
Read More
Women with pelvic pain turn to social media for condition information, management
March 1st 2022A survey in the American Journal of Obstetrics & Gynecology revealed that patients with chronic gynecologic pain were twice as likely to use social media to understand or manage their condition than those without pain, at 37.8% vs 19.7% respectively.
Read More
Perspectives on global women’s mental health
This diverse group of women came together to explore the challenges in treating mental illness in patients who identify as female.
Read More
Cytology dual-stain biomarker for detecting HPV-driven cervical precancer
December 27th 2021A prospective observational screening study has concluded a cytology dual-stain (DS) biomarker effectively triages women who test positive for primary human papillomavirus (HPV) and are at higher risk of developing cervical cancer, irrespective of the HPV genotype.
Read More